copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Angelini Pharma Angelini is committed to identifying health solutions with a prevalent focus on the areas of Central Nervous System (CNS), including pain, and Rare Diseases The Company is also a leading player in the Consumer Health sector,
Research and Development | Angelini Pharma Angelini Pharma has more than 50 years of expertise in research and development, from the discovery of new molecules up to the preclinical and clinical development of new pharmaceutical products, working at our labs as well as in collaboration with leading scientists worldwide
Key Financial - Angelini Pharma In 2024, Angelini Pharma consolidated revenues of €1,207 3 million (+3 6% vs 2023), with 50 6% generated in international markets, achieving an EBITDA of €302 4 million (+14% vs 2023) and an EBITDA margin of 25% (22 8% in 2023), with R D investments also increasing to €62 million: growth reflecting a commitment to innovation and quality care
Angelini Pharma at EAN Congress 2025: rethinking seizure control, together Angelini Pharma’s participation in EAN 2025 embodies its ongoing mission to foster meaningful scientific exchange, support healthcare professionals with the latest evidence, and drive forward innovations that can transform the standard of care
Angelini Pharma acquires Arvelle Therapeutics Following Angelini Pharma’s acquisition of Arvelle Therapeutics, Angelini Pharma will have the exclusive license to commercialize cenobamate in the European Union and other countries in the European Economic Area (Switzerland and the United Kingdom)
Epilepsy - Angelini Pharma 50 million people worldwide live with Epilepsy, the sixth neurological disease in terms of mortality, with 400,000 new cases every year only in Europe Find out more about Angelini Pharma's commitment in this area
Sustainability - Angelini Pharma At Angelini Pharma, we have adopted a scientific approach to measure our impact on climate change, calculating the carbon footprint for direct, indirect, and entire value chain emissions